Skip to content
Home/Companies/HealthTech/PredictImmune

PredictImmune

HealthTech·UK·Exited 2024·Held 5yr
Entry
2019
Hold
5yr
Exit
2024

Who owns PredictImmune?

PredictImmune was owned by Cambridge Innovation Capital through CIC Fund I (2013 vintage) from 2019 to 2024.

Hand-verified · updated 2026-06-21

Cambridge Innovation Capital
Investor
Cambridge Innovation Capital
CIC Fund I · 2013 · VC

Key facts

HQUK
SectorHealthTech
StatusAcquired
Exit Type
–
Buyer
–
MOIC
–
Exit Year
2024

More from CIC Fund I

Other portfolio companies in the same fund.

Seldon
Seldon
Exited 2026
AI/MLUK· 2020
to
Gyroscope Therapeutics
Gyroscope Therapeutics
Exited 2021
BiotechUK· 2019
to
Sense Biodetection
Sense Biodetection
Active
MedTechUK· 2019
Audio Analytic
Exited 2022
AI/MLUK· 2017
to
Cytora
Cytora
Exited 2025
InsurTechUK· 2017
to
Riverlane
Riverlane
Active
Deep TechUK· 2017

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
agilon health
agilon health
Active
CD&RUS
Akrivia Health
Akrivia Health
Active
Future Planet CapitalUK
Track PredictImmune

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy PredictImmune?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on PredictImmune.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue